Financhill
Sell
30

XTLB Quote, Financials, Valuation and Earnings

Last price:
$1.66
Seasonality move :
8.29%
Day range:
$1.66 - $1.77
52-week range:
$0.77 - $4.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.56x
Volume:
10K
Avg. volume:
15.8K
1-year change:
81.3%
Market cap:
$14.6M
Revenue:
--
EPS (TTM):
-$0.20

Earnings Data

Next earnings date for XTLB
Apr 30
2025
Most recent earnings per share
-$0.16
Missed by $0.16
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XTLB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2024 Q3 -- $162K -$0.16 -- --
06/30/2024 Q2 -- -- -$0.14 -- --
05/13/2024 Q1 -- -- $0.10 -- --
12/31/2023 Q4 -- -- -- -- --
09/30/2023 Q3 -- -- -$0.06 -- --
06/30/2023 Q2 -- -- -$0.07 -- --
03/31/2023 Q1 -- -- -$0.17 -- --
12/31/2022 Q4 -- -- -$0.10 -- --
09/30/2022 Q3 -- -- -$0.14 -- --
06/30/2022 Q2 -- -- -$0.10 -- --
03/31/2022 Q1 -- -- $0.01 -- --
12/31/2021 Q4 -- -- $0.26 -- --
09/30/2021 Q3 -- -- -$0.10 -- --
06/30/2021 Q2 -- -- -$0.20 -- --
03/31/2021 Q1 -- -- $0.10 -- --
12/31/2020 Q4 -- -- -$0.20 -- --
09/30/2020 Q3 -- -- -- -- --
06/30/2020 Q2 -- -- -$0.13 -- --
03/31/2020 Q1 -- -- $0.01 -- --
12/31/2019 Q4 -- -- -$0.25 -- --
09/30/2019 Q3 -- -- -$0.25 -- --
06/30/2019 Q2 -- -- -$0.60 -- --
03/31/2019 Q1 -- -- $0.80 -- --
12/31/2018 Q4 -- -- $0.20 -- --
09/30/2018 Q3 -- -- $0.20 -- --
06/30/2018 Q2 -- -- -$0.20 -- --
06/15/2018 Q1 -- -- $0.40 -- --
03/30/2018 Q4 -- -- -- -- --
12/06/2017 Q3 -- -- $0.40 -- --
06/30/2017 Q2 -- -- -$0.27 -- --
06/15/2017 Q1 -- -- -$0.30 -- --
03/30/2017 Q4 -- -- -$0.40 -- --
12/06/2016 Q3 -- -- -$0.10 -- --
09/27/2016 Q2 -- -- -$0.20 -- --
06/01/2016 Q1 -- -- -$0.20 -- --
04/26/2016 Q4 -- -- -$0.90 -- --
12/01/2015 Q3 -- -- -$0.20 -$0.05 -$0.15
09/01/2015 Q2 -- -- -$0.10 -- --
06/01/2015 Q1 -- -- -$0.50 -- --

XTL Biopharmaceuticals Earnings Questions

  • How Much did XTL Biopharmaceuticals Generate in Revenue Last Quarter?

    XTL Biopharmaceuticals reported $162K worth of top line sales in its most recent quarter.

  • Did XTL Biopharmaceuticals Beat Earnings Last Quarter?

    XTL Biopharmaceuticals announced earnings per share of -$0.16 which represents a miss of analyst forecast a -- per share.

  • Is XTL Biopharmaceuticals Profitable?

    XTL Biopharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for XTL Biopharmaceuticals EPS Next Year?

    XTL Biopharmaceuticals's earnings are forecast to grow from -$0.30 per share to -- per share next year representing an increase of --.

  • When is XTL Biopharmaceuticals's Earnings Date?

    XTL Biopharmaceuticals's next earnings date is April 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Trump Presidency Means For Stock Market
What Trump Presidency Means For Stock Market

Donald Trump was the first president in modern U.S. history…

Where Will TJX Companies Stock Be in 10 Years?
Where Will TJX Companies Stock Be in 10 Years?

Off-price retail is as popular as ever thanks to social…

Will CVS Health Stock Recover?
Will CVS Health Stock Recover?

It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 16

Quantum [QMCO] is down 0% over the past day.

Buy
51
QRVO alert for Jan 16

Qorvo [QRVO] is down 0% over the past day.

Sell
31
ATEX alert for Jan 16

Anterix [ATEX] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock